-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Cerus Co. (NASDAQ:CERS) Short Interest Update
Cerus Co. (NASDAQ:CERS) Short Interest Update
Cerus Co. (NASDAQ:CERS – Get Rating) was the target of a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 7,050,000 shares, an increase of 20.5% from the August 15th total of 5,850,000 shares. Based on an average daily trading volume, of 1,630,000 shares, the days-to-cover ratio is currently 4.3 days. Approximately 4.1% of the shares of the stock are short sold.
Insider Buying and Selling
In related news, insider Richard J. Benjamin sold 10,000 shares of the company's stock in a transaction on Tuesday, August 9th. The stock was sold at an average price of $5.12, for a total transaction of $51,200.00. Following the completion of the sale, the insider now directly owns 172,665 shares in the company, valued at approximately $884,044.80. The sale was disclosed in a filing with the SEC, which is available through this link. 7.33% of the stock is owned by corporate insiders.
Get Cerus alerts:Hedge Funds Weigh In On Cerus
Institutional investors and hedge funds have recently bought and sold shares of the company. Bank of America Corp DE increased its stake in shares of Cerus by 22.4% in the fourth quarter. Bank of America Corp DE now owns 326,525 shares of the biotechnology company's stock valued at $2,223,000 after buying an additional 59,839 shares during the period. BNP Paribas Arbitrage SA increased its stake in shares of Cerus by 50.0% in the fourth quarter. BNP Paribas Arbitrage SA now owns 44,982 shares of the biotechnology company's stock valued at $306,000 after buying an additional 15,003 shares during the period. Teacher Retirement System of Texas increased its stake in shares of Cerus by 22.7% in the fourth quarter. Teacher Retirement System of Texas now owns 33,292 shares of the biotechnology company's stock valued at $227,000 after buying an additional 6,168 shares during the period. Renaissance Technologies LLC increased its stake in shares of Cerus by 485.7% in the fourth quarter. Renaissance Technologies LLC now owns 642,473 shares of the biotechnology company's stock valued at $4,375,000 after buying an additional 532,773 shares during the period. Finally, MQS Management LLC acquired a new stake in Cerus during the fourth quarter worth approximately $69,000. Institutional investors and hedge funds own 84.72% of the company's stock.
Cerus Price Performance
CERS traded down $0.16 on Friday, reaching $3.85. The stock had a trading volume of 2,590,238 shares, compared to its average volume of 1,489,813. Cerus has a fifty-two week low of $3.69 and a fifty-two week high of $8.06. The firm has a 50-day moving average of $4.91 and a 200-day moving average of $5.07. The company has a current ratio of 2.08, a quick ratio of 1.73 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $681.80 million, a price-to-earnings ratio of -16.04 and a beta of 1.14.About Cerus
(Get Rating)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Further Reading
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It's a Down Week
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
Cerus Co. (NASDAQ:CERS – Get Rating) was the target of a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 7,050,000 shares, an increase of 20.5% from the August 15th total of 5,850,000 shares. Based on an average daily trading volume, of 1,630,000 shares, the days-to-cover ratio is currently 4.3 days. Approximately 4.1% of the shares of the stock are short sold.
賽樂斯股份有限公司(納斯達克代碼:CERS-GET Rating)是空頭股數8月份大幅上調的目標。截至8月31日,空頭股數共有705萬股,比8月15日的585萬股增加了20.5%。根據日均成交量1,630,000股,目前天數與回補比率為4.3天。大約4.1%的股票被賣空。
Insider Buying and Selling
內幕買賣
In related news, insider Richard J. Benjamin sold 10,000 shares of the company's stock in a transaction on Tuesday, August 9th. The stock was sold at an average price of $5.12, for a total transaction of $51,200.00. Following the completion of the sale, the insider now directly owns 172,665 shares in the company, valued at approximately $884,044.80. The sale was disclosed in a filing with the SEC, which is available through this link. 7.33% of the stock is owned by corporate insiders.
在相關新聞中,內部人士理查德·J·本傑明在8月9日星期二的一筆交易中出售了10,000股該公司股票。該股以5.12美元的平均價格出售,總成交金額為51,200.00美元。出售完成後,這位內部人士現在直接擁有該公司172,665股,價值約884,044.80美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過以下鏈接獲得。7.33%的股份由企業內部人士持有。
Hedge Funds Weigh In On Cerus
對衝基金看好Cerus
Institutional investors and hedge funds have recently bought and sold shares of the company. Bank of America Corp DE increased its stake in shares of Cerus by 22.4% in the fourth quarter. Bank of America Corp DE now owns 326,525 shares of the biotechnology company's stock valued at $2,223,000 after buying an additional 59,839 shares during the period. BNP Paribas Arbitrage SA increased its stake in shares of Cerus by 50.0% in the fourth quarter. BNP Paribas Arbitrage SA now owns 44,982 shares of the biotechnology company's stock valued at $306,000 after buying an additional 15,003 shares during the period. Teacher Retirement System of Texas increased its stake in shares of Cerus by 22.7% in the fourth quarter. Teacher Retirement System of Texas now owns 33,292 shares of the biotechnology company's stock valued at $227,000 after buying an additional 6,168 shares during the period. Renaissance Technologies LLC increased its stake in shares of Cerus by 485.7% in the fourth quarter. Renaissance Technologies LLC now owns 642,473 shares of the biotechnology company's stock valued at $4,375,000 after buying an additional 532,773 shares during the period. Finally, MQS Management LLC acquired a new stake in Cerus during the fourth quarter worth approximately $69,000. Institutional investors and hedge funds own 84.72% of the company's stock.
機構投資者和對衝基金最近買賣了該公司的股票。第四季度,美國銀行(Bank Of America Corp)增持Cerus股票22.4%。美國銀行DE現在擁有326,525股生物技術公司的股票,價值2223,000美元,在此期間又購買了59,839股。法國巴黎銀行套利SA在第四季度增持Cerus股份50.0%。法國巴黎銀行套利公司現在持有這家生物技術公司44,982股股票,價值306,000美元,在此期間又購買了15,003股。德州教師退休系統第四季增持Cerus股份22.7%德克薩斯州的教師退休系統現在擁有33,292股這家生物技術公司的股票,價值227,000美元,在此期間又購買了6,168股。復興科技有限責任公司在第四季度增持了Cerus的股份485.7%。復興科技有限責任公司現在擁有這家生物技術公司642,473股票,價值4375,000美元,在此期間又購買了532,773股票。最後,MQS Management LLC在第四季度收購了Cerus價值約6.9萬美元的新股份。機構投資者和對衝基金持有該公司84.72%的股票。
Cerus Price Performance
Cerus性價比
About Cerus
關於Cerus
(Get Rating)
(獲取評級)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Cerus公司是一家生物醫藥產品公司。該公司專注於開發攔截血液系統並將其商業化,以增強血液安全。其攔截血液系統,這是一項控制生物複製的專利技術,旨在減少用於輸血的捐獻血液成分中的血源性病原體。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It's a Down Week
- 免費獲取StockNews.com關於Cerus的研究報告(CERS)
- 第四季度值得考慮的3家銀行
- 股市:紅海中的三座強國
- MarketBeat:回顧一週9/12-9/16
- 有什麼辦法可以治癒Teladoc股票的問題嗎?
- 沒有人告訴這三隻股票這是下跌的一週
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Cerus Daily》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cerus和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧